Skip to main content

COVID-19 vaccine: SPIKEVAX (elasomeran)

The TGA has provisionally approved the Moderna COVID-19 vaccine, SPIKEVAX, for use in individuals aged 6 months to less than 6 years.

Published
Last updated

Related content

Help us improve the Therapeutic Goods Administration site